-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESBlog
DIA Recap: Tuesday, June 16
Jun 16, 2020
The DIA 2020 community just completed another full day of meaningful dialogue – virtually! This year’s conference offers attendees and the industry the opportunity for new digital learning options. Today we are highlighting several on-demand educational sessions featuring IQVIA’s thought leaders. We hope these recaps help to continue important conversations about advancing human health in tangible ways today and in the future:
- “Combination Therapies of Investigational Agents,” included Katie Laessig, MD, vice president of Therapeutic Strategy for Design and Delivery Innovation, as a panelist. Given this area requires layers of technical and regulatory consideration, Katie and fellow medical professionals educated the audience on a realm of requirements needed to support the development of combination therapies of investigational drugs, such as how to determine optimal regimen in the combination dose escalation. Katie and the panel focused on relevant U.S.-specific regulations as they discussed examples from case studies of the types of supporting evidence needed to commercially register these combination products.
- For the “Impact of Advanced Data Analytics Capabilities on Quality and Compliance Activities” forum, a panel of data and analytics experts, including Rajneesh Patil, senior director, Clinical Operations at IQVIA, spoke about how to apply data analytics techniques to enhance quality control of clinical research. Rajneesh shed light on the value of implementing artificial intelligence and machine learning solutions to better assess site risk and compliance in research. These models support important early detection of safety signals and offering predictive models for adverse event patterns and risks, which in turn leads to enhanced data quality and quicker and better decision-making with patient safety in mind.
- During a session simply titled “Wearables,” Sabrina Steffen, senior director, Data Management Innovation, Data Sciences, Safety & Regulatory, IQVIA, co-led a discussion exploring the legal, regulatory and practical issues surrounding the use of wearables and related data use in clinical practice. Sabrina laid out the numerous ways this data can be used in practice — from trials to patient monitoring to early diagnosis — and all the challenges to consider for innovators, including patient consent processes and legal and regulatory frameworks.
- Uwe Trinks, Global Practice lead, IQVIA, joined the on-demand panel “Data Related International Policy and Strategy: EudraVigilance Database (EVDAS)” to discuss the regulatory perspective regarding the use of EVDAS to further evaluate validated signals and solutions for handling data from this large database. The session also shared key elements critical to pharmaceutical companies’ compliance with the European General Data Protection Regulation, which protects personal data.
Additionally, several IQVIA subject matter experts are sharing their research and insights in the Professional Poster E-Gallery:
- PP07-54: Global Pharmacovigilance Strategic Management and Oversight: Study of a Partnership Model by Anand Haruger, director, Service Operations, Pharmacovigilance Project Leadership and Strategic Solutions
- PP02-25: Socio-Ecological Elements Involved in Racial and Ethnic Minority Recruitment Practices for Industry-Sponsored Clinical Trials by Becky Johnson, associate director, Global Patient and Site Solutions Strategy
- PP12-89: Reimbursement of Orphan Drugs in EU-5 between 2010-2019: A Landscape Assessment by Tulika Paul, associate consultant
Here we are at the end of another jam-packed, insightful day at the virtual DIA 2020 Annual Meeting, covering topics that help the industry from trial design and planning all the way through to commercialization. And there’s still more to come, so stay tuned!
For DIA 2020 attendees and others interested in connecting with IQVIA thought leaders at the conference, please visit the IQVIA virtual booth or contact us here. Let’s keep the conversations around advancing human health moving forward together.